Skip to main content
SpringerLink
Log in
Book cover
  • Conference proceedings
  • © 2013

Theranostics, Gallium-68, and Other Radionuclides

A Pathway to Personalized Diagnosis and Treatment

Editors:

  1. Richard P. Baum

    1. , THERANOSTICS Center for Molecular,, ENETS Center of Excellence, Bad Berka, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Frank Rösch

    1. Inst. Kernchemie, Universität Mainz, Mainz, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Examines in detail the latest developments in theranostics for neuroendocrine tumors and other diseases
  • Covers a wide spectrum of topics, from radiochemistry to clinical applications
  • Focuses on gallium-68 but also considers other PET radionuclides
  • Includes supplementary material: sn.pub/extras

Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 194)

Sections

Buy it now

eBook USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (34 papers)

  1. Molecular Imaging Using Ga-68 labeled Tracers

    2. Differential Uptake of 68Ga-DOTATOC and 68Ga-DOTATATE in PET/CT of Gastroenteropancreatic Neuroendocrine Tumors

      • Thorsten D. Poeppel, Ina Binse, Stephan Petersenn, Harald Lahner, Matthias Schott, Gerald Antoch et al.
      Pages 353-371

    3. High Uptake of 68Ga-DOTATOC in Spleen as Compared to Splenosis: Measurement by PET/CT

      • Harshad R. Kulkarni, Vikas Prasad, Daniel Kaemmerer, Merten Hommann, Richard P. Baum
      Pages 373-378

    4. Rare Metastases Detected by 68Ga-Somatostatin Receptor PET/CT in Patients with Neuroendocrine Tumors

      • Cecilia Carreras, Harshad R. Kulkarni, Richard P. Baum
      Pages 379-384

    5. Comparison of Different Positron Emission Tomography Tracers in Patients with Recurrent Medullary Thyroid Carcinoma: Our Experience and a Review of the Literature

      • Giorgio Treglia, Paola Castaldi, Maria Felicia Villani, Germano Perotti, Angelina Filice, Valentina Ambrosini et al.
      Pages 385-393

    6. PET Lung Ventilation/Perfusion Imaging Using 68Ga Aerosol (Galligas) and 68Ga-Labeled Macroaggregated Albumin

      • S. J. Ament, S. Maus, H. Reber, H. G. Buchholz, N. Bausbacher, C. Brochhausen et al.
      Pages 395-423

    7. Combined PET/MR Imaging Using 68Ga-DOTATOC for Radiotherapy Treatment Planning in Meningioma Patients

      • Daniela Thorwarth, Arndt-Christian Müller, Christina Pfannenberg, Thomas Beyer
      Pages 425-439

  2. Targeted Radiotherapy (Peptide Receptor Radionuclide Therapy) and Dosimetry

    1. Front Matter

      Pages 441-441
      PDF

    2. A Rare Case of a Large Spinal Meningioma with Mediastinal Extension and Malignant Behavior Classified Histologically as Benign

      • S. Dahdal, R. H. Andres, E. Hewer, J. C. Reubi, B. Klaeser, A. Raabe et al.
      Pages 443-455

    3. Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors in Germany: First Results of a Multi-institutional Cancer Registry

      • Dieter Hörsch, Samer Ezziddin, Alexander Haug, Klaus Friedrich Gratz, Simone Dunkelmann, Bernd Joachim Krause et al.
      Pages 457-465

    4. Polish Experience in Peptide Receptor Radionuclide Therapy

      • Jolanta Kunikowska, Leszek Królicki, Anna Sowa-Staszczak, Alicja Hubalewska-Dydejczyk, Dariusz Pawlak, Renata Mikolajczak et al.
      Pages 467-478

    5. PRRT as Neoadjuvant Treatment in NET

      • Anna Sowa-Staszczak, Alicja Hubalewska-Dydejczyk, Monika Tomaszuk
      Pages 479-485

    7. Personalized Image-Based Radiation Dosimetry for Routine Clinical Use in Peptide Receptor Radionuclide Therapy: Pretherapy Experience

      • Anna Celler, Joshua Grimes, Sergey Shcherbinin, Hanna Piwowarska-Bilska, Bozena Birkenfeld
      Pages 497-517

    8. The Bad Berka Dose Protocol: Comparative Results of Dosimetry in Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE, 177Lu-DOTANOC, and 177Lu-DOTATOC

      • Christiane Schuchardt, Harshad R. Kulkarni, Vikas Prasad, Carolin Zachert, Dirk Müller, Richard P. Baum
      Pages 519-536

    11. Is There a Correlation Between Peptide Receptor Radionuclide Therapy-Associated Hematological Toxicity and Spleen Dose?

      • Harshad R. Kulkarni, Vikas Prasad, Christiane Schuchardt, Richard P. Baum
      Pages 561-566
Back to top

About this book

This book is based on contributions presented at the 1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy, which examined recent developments in theranostics – the emerging field of molecular targeting of vectors that can be used for both diagnosis and therapy, when modified accordingly. The focus of this book is on the rapidly developing research into and clinical applications of gallium-68 and other generator-produced PET radionuclides in the personalized diagnosis and treatment of neuroendocrine tumors and other diseases. In addition, new PET radiopharmaceuticals are considered, and the latest ideas and concepts, presented. Theranostics embodies both molecular and personalized medicine. It is at the cutting edge of medicine, and the contents of this volume will be of interest to chemists, physicians, and investigators dealing with generators, PET radiochemistry, molecular imaging, and radionuclide therapy.
Back to top

Keywords

Back to top

Reviews

From the reviews:

“The general themes of this book (theranostics and peptide receptor–targeted radiotherapy) derive from evolving successes in the use of generator-produced 68Ga for molecular imaging of disease. … This book is an excellent resource for investigators interested in gaining a detailed understanding of the state of the art in 68Ga and peptide receptor radionuclide therapy–based theranostics for preclinical and emerging clinical applications.” (Michael K. Schultz, The Journal of Nuclear Medicine, Vol. 54 (4), April, 2013)
Back to top

Editors and Affiliations

  • , THERANOSTICS Center for Molecular,, ENETS Center of Excellence, Bad Berka, Germany

    Richard P. Baum

  • Inst. Kernchemie, Universität Mainz, Mainz, Germany

    Frank Rösch

Back to top

Bibliographic Information

  • Book Title: Theranostics, Gallium-68, and Other Radionuclides

  • Book Subtitle: A Pathway to Personalized Diagnosis and Treatment

  • Editors: Richard P. Baum, Frank Rösch

  • Series Title: Recent Results in Cancer Research

  • DOI: https://doi.org/10.1007/978-3-642-27994-2

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer-Verlag Berlin Heidelberg 2013

  • Hardcover ISBN: 978-3-642-27993-5Published: 23 August 2012

  • Softcover ISBN: 978-3-642-44160-8Published: 20 September 2014

  • eBook ISBN: 978-3-642-27994-2Published: 23 August 2012

  • Series ISSN: 0080-0015

  • Series E-ISSN: 2197-6767

  • Edition Number: 1

  • Number of Pages: XVIII, 578

  • Topics: Oncology, Nuclear Medicine, Neuroradiology, Radiotherapy, Molecular Medicine

  • Industry Sectors: Biotechnology, Health & Hospitals, Pharma

Back to top

Publish with us

Policies and ethics

Back to top
Access via your institution

Buy it now

eBook USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Search

Navigation